Athenahealth CEO Jonathan Bush leaves, board says it will consider sale or merger

Bush’s exit comes as previous charges of sexual harassment and domestic abuse surface amid activist investor’s nearly $7 billion takeover bid.
By Bernie Monegain
09:28 AM
Share
Athenahealth CEO Jonathan Bush leaves company

Athenahealth announced Wednesday morning that founder and CEO Jonathan Bush is leaving the company and that the board will consider “strategic alternatives.”

Those include hiring a new chief executive officer as well as a “sale, merger or other transaction involving the company as well as continuing as an independent company,” athenahealth said in a statement.

Bush’s departure follows negative reports about sexual harassment, a video with lewd comments at a 2017 healthcare industry event and domestic abuse in 2006 during a divorce.

It also comes just days after an investment expert suggested that athenahealth could essentially ignore activist investor Elliott Management’s takeover bid.

Bush co-founded the cloud-based EHR, practice management, revenue cycle and population health vendor in 1997.

"I believe that working for something larger than yourself is the greatest thing a human can do. A family, a cause, a company, a country – these things give shape and purpose to an otherwise mechanical and brief human existence. Athenahealth is a near once-in-a lifetime example of such a thing,” Bush said in a statement. “With that lens on, it's easy for me to see that the very things that made me useful to the company and cause in these past 21 years, are now exactly the things that are in the way. I cannot imagine a single organization more loaded with potential to transform healthcare."

The athenahealth Board of Directors, headed by former GE CEO Jeffrey Immelt, has initiated a search process to identify qualified CEO candidates. The board is working to better position athenahealth to capitalize on its healthcare technology platform, Immelt said. In the meantime, Immelt has been appointed Executive Chairman.

CFO Marc Levine will assume greater day-to-day operational responsibilities and oversight, and current board member Amy Abernethy, MD, will be advising the executive leadership team on data strategy within her role as a director, the company said.

“There can be no assurance that the review being undertaken will result in a merger, sale or other business combination involving the company,” athenahealth said. “athenahealth does not intend to make further announcements regarding the review unless and until the Board has approved a specific transaction or other course of action requiring disclosure.”

Twitter: @Bernie_HITN
Email the writer: bernie.monegain@himssmedia.com